Correlation Between Veracyte and Compugen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veracyte and Compugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Compugen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Compugen, you can compare the effects of market volatilities on Veracyte and Compugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Compugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Compugen.

Diversification Opportunities for Veracyte and Compugen

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Veracyte and Compugen is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Compugen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compugen and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Compugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compugen has no effect on the direction of Veracyte i.e., Veracyte and Compugen go up and down completely randomly.

Pair Corralation between Veracyte and Compugen

Given the investment horizon of 90 days Veracyte is expected to generate 0.72 times more return on investment than Compugen. However, Veracyte is 1.39 times less risky than Compugen. It trades about 0.39 of its potential returns per unit of risk. Compugen is currently generating about 0.03 per unit of risk. If you would invest  3,374  in Veracyte on September 1, 2024 and sell it today you would earn a total of  921.00  from holding Veracyte or generate 27.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Veracyte  vs.  Compugen

 Performance 
       Timeline  
Veracyte 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.
Compugen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Compugen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Veracyte and Compugen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veracyte and Compugen

The main advantage of trading using opposite Veracyte and Compugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Compugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will offset losses from the drop in Compugen's long position.
The idea behind Veracyte and Compugen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated